Claudia Lengerke

42PUBLICATIONS
213CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsHaematologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 18, 2026
Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia.

|Aug 12, 2026
Hormone levels of female patients with SLE after anti-CD19 CAR T-cell treatment do not indicate a signal of impaired ovarian reserve.

|Nov 25, 2025
Predictive capacity of peritransplant measurable residual disease thresholds in NPM1-mutant acute myeloid leukemia.

Jan Christian Schroeder, Friederike Schwartz, Judith Metzdorf

|Jul 29, 2025
Casein kinase 1α essentially regulates thrombopoiesis by driving megakaryocyte maturation and cytoskeleton organization.

Ferdinand Kollotzek, Kristina Mott, Melina Fischer

|Apr 14, 2025
Trends in Overall Survival in Lung Adenocarcinoma with EGFR Mutation, KRAS Mutation, or No Mutation.

Martin Faehling, Sabine Fallscheer, Birgit Schwenk

|Apr 06, 2025
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution.

Andreas Riedel, Laurent Phely, Stefan Hug

Pageof 7

Frequent Collaborators

14 joint publications

Wolfgang Bethge

6 joint publications

Jan Schröder

5 joint publications

Martina Konantz

4 joint publications

Lucas Mix